Prognostic value of survival in patients with advanced non-small cell lung cancer treated with tyrosine-kinase inhibitors: Value of SUVmax or value of other factor?
Year: 2025
Type: article
Study design: Observational Study
Source: PubMed
DOI: 10.7417/ct.2025.5165
Authors: T Pham-Van, T C Bui, C P Pham, L T Le, T K Mai, B D Nguyen, H T Vo-Thi, Q H Nguyen
Institutions: Hanoi Medical University, Bạch Mai Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4407675962